About Ajeet Gajra, MD, MBBS, FACP

1 POSTS 0 COMMENTS

Dr. Gajra is Vice President, Chief Medical Officer for Cardinal Health Specialty Solutions. A nationally recognized expert in lung cancer and geriatric oncology, Dr. Gajra is an ABIM board-certified medical oncologist/hematologist, with more than 16 years of clinical experience managing all types of cancer and blood disorders.

Survey Finds Oncologists Have Grown More Comfortable With CAR-T Therapy

Ajeet Gajra, MD, MBBS, FACP - August 23, 2021

LATEST NEWS

Court Confirms Sorrento’s US $125 Million Arbitration Award Against NantPharma

Editorial Team - March 17, 2023

Pfizer Agrees to Acquire Seagen for US $ 43 Billion

Editorial Team - March 13, 2023

Byondis Plans First-in-human Dose Escalation/Expansion Study With the SIRPα-directed BYON4228

Danielle Garcia - February 27, 2023

FDA Priority Review of NDA for Nirogacestat for the Treatment of Rare Desmoid Tumors

Editorial Team - February 27, 2023

Finding a Cure for Nonalcoholic Fatty Liver Disease

Editorial Team - February 23, 2023

Press Releases | Cancer

CHC and Merck partner to advance more equitable health outcomes in... March 21, 2023
The collaboration aims to advance health equity and improve health outcomes for people at risk for breast and cervical cancers in underserved communities by creating a scalable model for prevention...(PRWeb March 21, 2023)Read the full story at https://www.prweb.com/releases/chc_and_merck_partner_to_advance_more_equitable_health_outcomes_in_breast_and_cervical_cancer_care_in_black_hispanic_and_other_underserved_populations/prweb19232973.htm
Unlocking the Power of Rick Simpson Oil: A Revolutionary Breakthrough... March 20, 2023
The power of Rick Simpson Oil (RSO) has been unlocked in an exciting new development. Used to treat a wide range of medical conditions and ailments, this oil is now more accessible than ever before.(PRWeb March 20, 2023)Read the full story at https://www.prweb.com/releases/unlocking_the_power_of_rick_simpson_oil_a_revolutionary_breakthrough_in_health_and_wellness/prweb19233768.htm
Deep Bio’s Novel Study Results Reaffirm Its Global Presence March 14, 2023
USCAP 2023 is Deep Bio’s sixth consecutive year of presenting research abstracts(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/03/prweb19209392.htm

Ajeet Gajra, MD, MBBS, FACP

Survey Finds Oncologists Have Grown More Comfortable With CAR-T Therapy

LATEST NEWS

Court Confirms Sorrento’s US $125 Million Arbitration Award Against NantPharma

Pfizer Agrees to Acquire Seagen for US $ 43 Billion

Byondis Plans First-in-human Dose Escalation/Expansion Study With the SIRPα-directed BYON4228

FDA Priority Review of NDA for Nirogacestat for the Treatment of Rare Desmoid Tumors

Finding a Cure for Nonalcoholic Fatty Liver Disease

Court Confirms Sorrento’s US $125 Million Arbitration Award Against NantPharma

Pfizer Agrees to Acquire Seagen for US $ 43 Billion

Byondis Plans First-in-human Dose Escalation/Expansion Study With the SIRPα-directed BYON4228

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...